Jun 06, 2023
149:100
For every 100 shares held, investors received 149. The price per share adjusted from $49.25 to $33.05.
The split itself did not change the total investment value.
Wuhan Easy Diagnosis Biomedicine Co., Ltd. Class A (SZSE:002932) operates in the Medical specialties industry.
Wuhan Easy Diagnosis Biomedicine Co., Ltd. Class A company overviewWuhan Easy Diagnosis Biomedicine Co., Ltd. Class A's most recent stock split was on June 6, 2023. It was a 149-for-100 forward split, so shareholders received 149 shares for every 100 they held.
Wuhan Easy Diagnosis Biomedicine Co., Ltd. Class A (SZSE:002932) has split its stock 3 times: a 7-for-5 split on July 20, 2021, a 149-for-100 split on June 21, 2022, and a 149-for-100 split on June 6, 2023.
Wuhan Easy Diagnosis Biomedicine Co., Ltd. Class A has split its stock 3 times. This history records 3 forward splits between July 20, 2021 and June 6, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Wuhan Easy Diagnosis Biomedicine Co., Ltd. Class A's 149-for-100 split on June 6, 2023, every 100 shares became 149 shares.
Wuhan Easy Diagnosis Biomedicine Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on June 6, 2023, 3 years ago. Companies announce splits in advance, and any new SZSE:002932 split will appear on this page.
Already premium?